pING-hHER3FL
N/A
Report date: 2026/05/12 09:09:25
Base Information
Drug NamepING-hHER3FL
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDuke University
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A